Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cisplatin and IMRT in Intermediate Risk Nasopharyngeal Carcinoma
NCT02289807Withdrawn
- Sponsor
- Sun Yat-sen University
- Start
- Mar 2015
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of cisplatin in nasopharyngeal carcinoma (NPC), sponsored by Sun Yat-sen University. Planned start Mar 2015; status: withdrawn.
02
Drugs
cisplatin
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02289807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289807.